PDC*line Pharma

Pdc*line pharma email format

Verified email-pattern data for Pdc*line Pharma is currently limited. You can still use the company insights and contact sections below.
PDC*line Pharma is a clinical-stage Biotechnology company that develops a new class of potent, off-the-shelf therapeutic cancer vaccines based on a proprietary cell line of Plasmacytoid Dendritic Cells (PDC*line). Based on a robust preclinical package and a first-in-human phase Ib in melanoma, PDC*line Pharma reported promising Phase I/II results in lung cancer (PDC*lung) in 2024. Preparations are now underway for a randomized Phase II trial in lung cancer, and a Phase Ib trial in colorectal cancer with neoantigens (PDC*neo). The company has raised €61M in equity and non-dilutive funding and signed a €108M licensing deal in Asia with the Korean pharmaceutical company, LG Chem Life Science.

Company Details

Employees
32
Founded
-
Address
Pdc*line Pharma Sa, Boulevard Patience Et Beaujonc N°3 Boîte 6, Liège,liège 4000,belgium
Phone
+33 (0) 4 84 35 05 04
Email
co****@****rma.com
Industry
Biotechnology Research
HQ
Liège, Liège
Looking for a particular PDC*line Pharma employee's phone or email?

Pdc*line Pharma Questions

Explore related pages

Related company profiles:

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant